199 related articles for article (PubMed ID: 29905911)
1. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma.
Zhou Y; He P; Xie X; Sun C
Mol Cell Biochem; 2019 Jan; 450(1-2):125-134. PubMed ID: 29905911
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SUMO1P3 acts as a prognostic biomarker and promotes hepatocellular carcinoma growth and metastasis.
Hu S; Liu J; Feng S; Wang Y; Liu H
Aging (Albany NY); 2021 Apr; 13(9):12479-12492. PubMed ID: 33902004
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
Wu S; Chen S; Lin N; Yang J
J Cell Mol Med; 2020 Mar; 24(5):3108-3116. PubMed ID: 31970876
[TBL] [Abstract][Full Text] [Related]
4. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
6. The tissue expression levels of SUMO1P 3 may be a reliable prognostic biomarker to predict the clinical outcomes in patients with HCC.
Yu H; Bai Y; Xu C; He X; Liu Q; Ma D; A Y
Medicine (Baltimore); 2020 Nov; 99(46):e21291. PubMed ID: 33181633
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
8. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
11. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
Du X; Fan W; Chen Y
Gene; 2018 May; 657():30-38. PubMed ID: 29505836
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
14. Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway.
Kong Y; Zhang L; Huang Y; He T; Zhang L; Zhao X; Zhou X; Zhou D; Yan Y; Zhou J; Xie H; Zhou L; Zheng S; Wang W
Cancer Lett; 2017 Oct; 407():76-83. PubMed ID: 28823960
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.
Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J
Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296
[TBL] [Abstract][Full Text] [Related]
17. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Zhang Y; Li Y; Han L; Zhang P; Sun S
Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548
[TBL] [Abstract][Full Text] [Related]
18. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
19. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]